L01AX03 • temozolomide • Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
Temozolomide is a chemotherapy agent used for the treatment of certain types of brain tumors, such as glioblastoma multiforme and anaplastic astrocytoma. It works by interfering with the DNA of tumor cells, thereby inhibiting their growth and division.
The medication is taken orally, usually once daily, as directed by a doctor. The dosage is adjusted based on body weight and the patient's overall condition.
Patients should be monitored for potential side effects, such as nausea, vomiting, or a decrease in blood cell counts. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, vomiting, fatigue, and loss of appetite. In rare cases, severe reactions such as myelosuppression or serious infections may occur. Patients should be informed of these risks before starting treatment.
Substance: temozolomide
Date of last drug list: 01-06-2025
Commercial code: W66251001
Concentration: 140mg
Pharmaceutical form: capsules
Quantity: 5
Product type: generic
Price: 342.04 RON
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. - OLANDA
Holder: SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. - OLANDA
Number: 697/2011/19
Shelf life: 2 years
